Abingdon Health Plc
Status: Publicly traded
Direct answer
Abingdon Health Plc is publicly traded on LSE under the ticker ABDX.L.
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately...
Can you invest in Abingdon Health Plc?
Yes. Abingdon Health Plc trades publicly on LSE as ABDX.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Abingdon Health Plc
Detailed equity research is provided by MarketSnap.